Patricia Green Bronson, AGNP-C | |
8101 Hinson Farm Rd, Alexandria, VA 22306-3403 | |
(703) 780-9014 | |
(703) 780-9077 |
Full Name | Patricia Green Bronson |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 4 Years |
Location | 8101 Hinson Farm Rd, Alexandria, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417586884 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Inova Alexandria Hospital | Alexandria, VA | Hospital |
Inova Mount Vernon Hospital | Alexandria, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Inova Health Care Services | 2466351093 | 1725 |
Inova Health Care Services | 2466351093 | 1725 |
News Archive
The American Association on Health and Disability is excited to expand its collaboration with the National Institutes of Health's All of Us Research Program.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of the range of guidance provided previously.
Like the plastic caps at the end of shoelaces, telomeres protect — in their case — the interior-gene containing parts of chromosomes that carry a cell's instructional material. Cancer cells are known to have short telomeres, but just how short they are from cancer cell to cancer cell may be a determining factor in a prostate cancer patient's prognosis, according to a study led by Johns Hopkins scientists.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on November 19, 2009, the Company received notice from the Nasdaq Listing Qualifications Panel that it has regained compliance with the shareholders' equity requirement for continued listing on the Nasdaq Capital Market.
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company's Board of Directors has declared a quarterly cash dividend of US$0.09 per share payable on January 4, 2010 to shareholders of record at the close of business December 2, 2009. The ex-dividend date is November 30, 2009.
› Verified 7 days ago
Entity Name | Inova Health Care Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
The American Association on Health and Disability is excited to expand its collaboration with the National Institutes of Health's All of Us Research Program.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of the range of guidance provided previously.
Like the plastic caps at the end of shoelaces, telomeres protect — in their case — the interior-gene containing parts of chromosomes that carry a cell's instructional material. Cancer cells are known to have short telomeres, but just how short they are from cancer cell to cancer cell may be a determining factor in a prostate cancer patient's prognosis, according to a study led by Johns Hopkins scientists.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on November 19, 2009, the Company received notice from the Nasdaq Listing Qualifications Panel that it has regained compliance with the shareholders' equity requirement for continued listing on the Nasdaq Capital Market.
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company's Board of Directors has declared a quarterly cash dividend of US$0.09 per share payable on January 4, 2010 to shareholders of record at the close of business December 2, 2009. The ex-dividend date is November 30, 2009.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Patricia Green Bronson, AGNP-C 2622 Hickory Hollow Ln, Oakton, VA 22124-1504 Ph: () - | Patricia Green Bronson, AGNP-C 8101 Hinson Farm Rd, Alexandria, VA 22306-3403 Ph: (703) 780-9014 |
News Archive
The American Association on Health and Disability is excited to expand its collaboration with the National Institutes of Health's All of Us Research Program.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of the range of guidance provided previously.
Like the plastic caps at the end of shoelaces, telomeres protect — in their case — the interior-gene containing parts of chromosomes that carry a cell's instructional material. Cancer cells are known to have short telomeres, but just how short they are from cancer cell to cancer cell may be a determining factor in a prostate cancer patient's prognosis, according to a study led by Johns Hopkins scientists.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on November 19, 2009, the Company received notice from the Nasdaq Listing Qualifications Panel that it has regained compliance with the shareholders' equity requirement for continued listing on the Nasdaq Capital Market.
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company's Board of Directors has declared a quarterly cash dividend of US$0.09 per share payable on January 4, 2010 to shareholders of record at the close of business December 2, 2009. The ex-dividend date is November 30, 2009.
› Verified 7 days ago
Ms. Meghan Rise, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6076 Franconia Rd Ste D, Alexandria, VA 22310 Phone: 855-484-7483 | |
Cheryl Jeanne Reynolds, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8109 Hinson Farm Rd, Suite 504, Alexandria, VA 22306 Phone: 703-780-2800 Fax: 703-780-2800 | |
Ms. Juliet Brown, MSN, CPNP-PC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5249 Duke St Ste 303, Alexandria, VA 22304 Phone: 703-823-7400 | |
Cathleen Scully, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6355 Walker Ln Ste 505, Alexandria, VA 22310 Phone: 703-971-4444 | |
Dr. James Gavin Wallace-mercado, DNP, MSN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6677 Richmond Hwy, Alexandria, VA 22306 Phone: 703-535-5568 | |
Luis Alberto Rivera Pena, FNP-BC, RN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8109 Hinson Farm Rd Ste 504, Alexandria, VA 22306 Phone: 703-780-2800 | |
Ms. Joanne F Charles, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6355 Walker Ln, Suite 310, Alexandria, VA 22310 Phone: 703-971-8600 Fax: 703-971-9043 |